ESTRO 2024 - Abstract Book

S2483

Clinical - Urology

ESTRO 2024

Conclusion:

By combining DVH-data from RT dose planning with data from the EPIC bowel questionnaires, it has been shown that it is clinically relevant to keep bowel cavity V50 Gy < 200ccm and V35 Gy < 40% in order to reduce acute bowel morbidity. As V50Gy is more or less given by the overlap between PTV and bowel cavity, focus should be paid to reduce V35Gy.

Keywords: Prostate cancer, adverse effects, EPIC

References:

[1] T. A. Skolarus, R. L. Dunn og M. G. Sanda. Minimally important difference for the expanded prostate cancer index composite short form. Urology, 85:101-106, 2015.

1997

Digital Poster

Ultra-hypofractionated radiotherpy in elderly prostate cancer patients: a single center experience

Ilaria Repetti 1,2 , Giulia Corrao 1 , Giulia Marvaso 1 , Chiara Lorubbio 1,2 , Federico Mastroleo 1 , Maria Giulia Vincini 1 , Mattia Zaffaroni 1 , Cristiana Fodor 1 , Vanessa Pierini 2 , Giovanni Carlo Mazzola 1 , Cristiana Pedone 2 , Dario Zerini 1 , Barbara Alicja Jereczek-Fossa 1,2 1 European Institute of Oncology, IRCCS, Division of Radiation Oncology, Milan, Italy. 2 University of Milan, Department of Oncology and Hemato-oncology, Milan, Italy

Purpose/Objective: